Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1319-1325

  Valenti, Luca ^a   Fracanzani, Anna Ludovica ^a   Rametta, Raffaela ^a   Fraquelli, Mirella ^a   Soverini, Giulia ^a   Pelusi, Serena ^a   Dongiovanni, Paola ^a   Conte, Dario ^a   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cirrhosis; Genetics; Hepatocellular carcinoma; Hepcidin; Hereditary hemochromatosis; HFE; Iron; Penetrance; TMPRSS6

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; HEPCIDIN;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PENETRANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS HEPATITIS;

ADULT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HEMOCHROMATOSIS; HUMANS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES;

EID: 84869210296     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.041     Document Type: Article

References (46)

1. A. Pietrangelo Hemochromatosis: an endocrine liver disease Hepatology 46 2007 1291 1301
2. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, and D.M. Ward Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
3. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
4. K.J. Allen, L.C. Gurrin, C.C. Constantine, N.J. Osborne, M.B. Delatycki, and A.J. Nicoll Iron-overload-related disease in HFE hereditary hemochromatosis N Engl J Med 358 2008 221 230
5. A. Pietrangelo Hereditary hemochromatosis-a new look at an old disease N Engl J Med 350 2004 2383 2397
6. S. Fargion, A.L. Fracanzani, A. Piperno, M. Braga, R. D'Alba, and G. Ronchi Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis Hepatology 20 1994 1426 1431
7. A.L. Fracanzani, A. Piperno, L. Valenti, M. Fraquelli, S. Coletti, and A. Maraschi Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors Hepatology 51 2010 501 510
8. M. Traglia, D. Girelli, G. Biino, N. Campostrini, M. Corbella, and C. Sala Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations J Med Genet 48 2011 629 634
9. P.C. Adams, D.M. Reboussin, J.C. Barton, C.E. McLaren, J.H. Eckfeldt, and G.D. McLaren Hemochromatosis and iron-overload screening in a racially diverse population N Engl J Med 352 2005 1769 1778
10. E. Beutler, V. Felitti, T. Gelbart, and N. Ho The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic Ann Intern Med 133 2000 329 337
11. P.D. Phatak, D.H. Ryan, J. Cappuccio, D. Oakes, C. Braggins, and K. Provenzano Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients Blood Cells Mol Dis 29 2002 41 47
12. J.K. Olynyk, D.J. Cullen, S. Aquilia, E. Rossi, L. Summerville, and L.W. Powell A population-based study of the clinical expression of the hemochromatosis gene N Engl J Med 341 1999 718 724
13. M.J. Wood, L.W. Powell, and G.A. Ramm Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis Blood 111 2008 4456 4462
14. D.D. Harrison-Findik, E. Klein, C. Crist, J. Evans, N. Timchenko, and J. Gollan Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol Hepatology 46 2007 1979 1985
15. D. Girelli, M. Pasino, J.B. Goodnough, E. Nemeth, M. Guido, and A. Castagna Reduced serum hepcidin levels in patients with chronic hepatitis C J Hepatol 51 2009 845 852
16. L. Valenti, D. Conte, A. Piperno, P. Dongiovanni, A.L. Fracanzani, and M. Fraquelli The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis J Med Genet 41 2004 946 950
17. S. Fargion, L. Valenti, P. Dongiovanni, A. Scaccabarozzi, A.L. Fracanzani, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis Blood 97 2001 3707 3712
18. A. Piperno, R. Mariani, C. Arosio, A. Vergani, S. Bosio, and S. Fargion Haemochromatosis in patients with beta-thalassaemia trait Br J Haematol 111 2000 908 914
19. L. Valenti, P. Maggioni, A. Piperno, R. Rametta, S. Pelucchi, and R. Mariani PNPLA3 I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis World J Gastroenterol 18 2012 2813 2820
20. P. Dongiovanni, A. Fracanzani, G. Cairo, C.P. Megazzini, S. Gatti, and R. Rametta Iron dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis Am J Pathol 176 2010 1006 1017 10.2353/amjpath.2010.090249
21. C.H. Osterreicher, C. Datz, F. Stickel, C. Hellerbrand, M. Penz, and H. Hofer Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis J Hepatol 42 2005 914 919
22. J. Milet, G. Le Gac, V. Scotet, I. Gourlaouen, C. Theze, and J. Mosser A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study Blood Cells Mol Dis 44 2010 34 37
23. L. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, and P. Maggioni Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease J Hepatol 53 2010 927 933
24. A.J. Ramsay, J.D. Hooper, A.R. Folgueras, G. Velasco, and C. Lopez-Otin Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis Haematologica 94 2009 840 849
25. D. Meynard, V. Vaja, C.C. Sun, E. Corradini, S. Chen, and C. Lopez-Otin Regulation of TMPRSS6 by BMP6 and iron in human cells and mice Blood 118 2011 747 756
26. K.E. Finberg Iron-refractory iron deficiency anemia Semin Hematol 46 2009 378 386
27. B. Benyamin, M.A. Ferreira, G. Willemsen, S. Gordon, R.P. Middelberg, and B.P. McEvoy Common variants in TMPRSS6 are associated with iron status and erythrocyte volume Nat Genet 41 2009 1173 1175
28. T. Tanaka, C.N. Roy, W. Yao, A. Matteini, R.D. Semba, and D. Arking A genome-wide association analysis of serum iron concentrations Blood 2009
29. J.C. Chambers, W. Zhang, Y. Li, J. Sehmi, M.N. Wass, and D. Zabaneh Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels Nat Genet 41 2009 1170 1172
30. A. Nai, A. Pagani, L. Silvestri, N. Campostrini, M. Corbella, and D. Girelli TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals Blood 2011
31. K.E. Finberg, R.L. Whittlesey, and N.C. Andrews Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice Blood 117 2011 4590 4599
32. P. Lee, M.H. Hsu, J. Welser-Alves, and H. Peng Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6 Blood Cells Mol Dis 48 2012 173 178
33. A. Nai, A. Pagani, G. Mandelli, M.R. Lidonnici, L. Silvestri, and G. Ferrari Deletion of Tmprss6 attenuates the phenotype in a mouse model of beta-thalassemia Blood 2012
34. P. Adams, P. Brissot, and L.W. Powell EASL International Consensus Conference on Haemochromatosis J Hepatol 33 2000 485 504
35. B.R. Bacon, P.C. Adams, K.V. Kowdley, L.W. Powell, and A.S. Tavill Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 2011 328 343
36. A. Guillygomarc'h, M.H. Mendler, R. Moirand, F. Laine, V. Quentin, and V. David Venesection therapy of insulin resistance-associated hepatic iron overload J Hepatol 35 2001 344 349
37. E.D. Morrison, D.J. Brandhagen, P.D. Phatak, J.C. Barton, E.L. Krawitt, and H.B. El-Serag Serum ferritin level predicts advanced hepatic fibrosis among US patients with phenotypic hemochromatosis Ann Intern Med 138 2003 627 633
38. L. Valenti, M. Varenna, A.L. Fracanzani, V. Rossi, S. Fargion, and L. Sinigaglia Association between iron overload and osteoporosis in patients with hereditary hemochromatosis Osteoporos Int 20 2009 549 555
39. L. Valenti, A.L. Fracanzani, V. Rossi, C. Rampini, E. Pulixi, and M. Varenna The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload J Rheumatol 35 2008 153 158
40. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
41. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
42. K.E. Finberg, M.M. Heeney, D.R. Campagna, Y. Aydinok, H.A. Pearson, and K.R. Hartman Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) Nat Genet 40 2008 569 571
43. P. Delbini, V. Vaja, G. Graziadei, L. Duca, I. Nava, and C. Refaldi Genetic variability of TMPRSS6 and its association with iron deficiency anaemia Br J Haematol 151 2010 281 Äì284
44. P. An, Q. Wu, H. Wang, Y. Guan, M. Mu, and Y. Liao TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia Hum Mol Genet 21 2012 2124 2131
45. A.J. Sanders, S.L. Webb, C. Parr, M.D. Mason, and W.G. Jiang The type II transmembrane serine protease, matriptase-2: possible links to cancer? Anticancer Agents Med Chem 10 2010 64 69
46. G.C. Preza, P. Ruchala, R. Pinon, E. Ramos, B. Qiao, and M.A. Peralta Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload J Clin Invest 121 2012 4880 4888